title: Ras pathway is required for the activation of MMP-2 secretion and for the invasion of src-transformed 3Y1.
abstract: To search for the signaling pathway critical for tumor invasion, we examined the effects of dominant negative ras (S17N ras) expression on the activation of matrix metalloproteinase-2 (MMP-2) in src-transformed 3Y1, SR3Y1, under the control of conditionally inducible promoter. In SR3Y1 clones transfected with S17N ras, augmented secretion and proteolytic activation of MMP-2 were dramatically suppressed by S17N Ras expression, while tyrosine phosphorylation of cellular proteins was not suppressed. We found that invasiveness of SR3Y1 cells assayed by the modified Boyden Chamber method was strongly suppressed by S17N Ras expression. In contrast, cell morphology reverted partially and glucose uptake remained unchanged by S17N Ras expression. In addition, treatment of SR3Y1 with manumycin A, a potent inhibitor of Ras farnesyltransferase, strongly suppressed both augmented secretion and proteolytic activation of MMP-2. Contrary, treatment of SR3Y1 with wortmannin or TPA showed no clear effect on MMP-2 activation. Thus, these results strongly suggest that Ras-signaling, but neither P13 kinase- nor protein kinase C-signalings, plays a critical role in activation of MMP-2 and, subsequently, in the invasiveness of src-transformed cells.
authors.affiliation: Department of Molecular Pathogenesis, Nagoya University School of Medicine, Japan.
authors.forename: A A
authors.initials: AA
authors.lastname: Thant
authors.forename: T T
authors.initials: TT
authors.lastname: Sein
authors.forename: E
authors.initials: E
authors.lastname: Liu
authors.forename: K
authors.initials: K
authors.lastname: Machida
authors.forename: F
authors.initials: F
authors.lastname: Kikkawa
authors.forename: T
authors.initials: T
authors.lastname: Koike
authors.forename: M
authors.initials: M
authors.lastname: Seiki
authors.forename: S
authors.initials: S
authors.lastname: Matsuda
authors.forename: M
authors.initials: M
authors.lastname: Hamaguchi
mesh_terms: D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D002461:Cell Line, Transformed; D002999:Clone Cells; D004789:Enzyme Activation; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D011090:Polyenes / Q000494:pharmacology; D053284:Polyunsaturated Alkamides; D016392:Proto-Oncogene Proteins pp60(c-src) / Q000235:genetics*; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D000077191:Wortmannin; D018631:ras Proteins / Q000378:metabolism*
chemical_list: D000730:Androstadienes; D011090:Polyenes; D053284:Polyunsaturated Alkamides; D016392:Proto-Oncogene Proteins pp60(c-src); D020778:Matrix Metalloproteinase 2; D018631:ras Proteins; D013755:Tetradecanoylphorbol Acetate; C054474:manumycin; D000077191:Wortmannin